Fleming T J, Donnadieu E, Song C H, Laethem F V, Galli S J, Kinet J P
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
J Exp Med. 1997 Oct 20;186(8):1307-14. doi: 10.1084/jem.186.8.1307.
Signaling through the high affinity receptor for immunoglobulin E (Fc epsilon RI) results in the coordinate activation of tyrosine kinases before calcium mobilization. Receptors capable of interfering with the signaling of antigen receptors, such as Fc epsilon RI, recruit tyrosine and inositol phosphatases that results in diminished calcium mobilization. Here, we show that antibodies recognizing CD81 inhibit Fc epsilon RI-mediated mast cell degranulation but, surprisingly, without affecting aggregation-dependent tyrosine phosphorylation, calcium mobilization, or leukotriene synthesis. Furthermore, CD81 antibodies also inhibit mast cell degranulation in vivo as measured by reduced passive cutaneous anaphylaxis responses. These results reveal an unsuspected calcium-independent pathway of antigen receptor regulation, which is accessible to engagement by membrane proteins and on which novel therapeutic approaches to allergic diseases could be based.
通过免疫球蛋白E高亲和力受体(FcεRI)发出的信号在钙动员之前会导致酪氨酸激酶的协同激活。能够干扰抗原受体信号传导的受体,如FcεRI,会募集酪氨酸和肌醇磷酸酶,从而导致钙动员减少。在这里,我们表明,识别CD81的抗体可抑制FcεRI介导的肥大细胞脱颗粒,但令人惊讶的是,这并不影响聚集依赖性酪氨酸磷酸化、钙动员或白三烯合成。此外,通过减少被动皮肤过敏反应来衡量,CD81抗体在体内也能抑制肥大细胞脱颗粒。这些结果揭示了一条意想不到的抗原受体调节的钙非依赖性途径,膜蛋白可以参与该途径,并且可以基于此开发治疗过敏性疾病的新方法。